Board of Directors
The Urology Care Foundation Board of Directors is led by the Foundation President and includes both AUA member urologists and public directors. The diverse perspectives and extensive knowledge of this group is invaluable as the Foundation continues to support and develop researchers, develop and disseminate patient education materials and support humanitarian efforts. The Board is committed to improving urological care globally.
The Urology Care Foundation is currently recruiting AUA members to join its Board of Directors for the open positions of Secretary and Member-At Large.
Read the Position Descriptions and Application Requirements
Harris M. Nagler, MD, FACS
Professor of Urology at Hofstra Northwell School of Medicine
Dr. Nagler previously served as President of Beth Israel Medical Center and Chair of the Sol and Margaret Berger Department of Urology at Beth Israel Medical Center and Professor of Urology at the Icahn School of Medicine at Mount Sinai. At Beth Israel he had also served as the Chief of Graduate Medical Education/Academic Affairs at the Beth Israel; the Program Director of the urology residency-training program, Chief Medical Officer and Physician-in-Chief. Dr Nagler's clinical practice focuses on male infertility, erectile dysfunction and general urology.
Badar Mian, MD
Albany Med Health System
Dr. Mian is currently professor of urology at Albany Med Health System in Albany, New York. Dr. Mian is a uro-oncologist with primary clinical and research focus the diagnostic and therapeutic strategies for prostate cancer and other genitourinary tract malignancies. He is actively engaged, with support of local donors, in engaging those from underprivileged areas within his region by providing free, open access to medical advice, and guidance on obtaining necessary health services. Activities have included providing urologic care to non-English speaking new immigrants or refugees, especially women, through the support of volunteer physician, advanced practice providers and nurses. He has also developed a regional core group of professionals and volunteers who coordinate medical care, social services, food pantry and soup kitchen that are largely supported by individual donors.
Dr. Mian is a supporter of the Urology Care Foundation’s efforts to expand its humanitarian program to treat and train physicians to support underserved areas and has been instrumental in endowing two Humanitarian Endowment funds.
Thomas F. Stringer, MD, FACS
Clinical Associate Professor in the Department of Urology at the University of Florida (UF) in Gainesville
Thomas F. Stringer, MD, FACS is Clinical Associate Professor in the Department of Urology at the University of Florida (UF) in Gainesville and also serves as Associate Chairman of Philanthropy and Alumni Affairs. Dr. Stringer received his undergraduate degree from the University of Michigan and his medical degree from Wayne State University in Detroit, Michigan. He completed his residency in surgery and urology at the UF College of Medicine in 1980.
Dr. Stringer is Past-President the AUA Southeastern Section (2009 – 2010) and the Florida Urological Society (2006 – 2007). He served on the AUA's Finance, Bylaws and Investment Committees and was Chairman of the AUA Compensation Committee. He served as the Southeastern Section representative to the AUA Board of Directors (2014 – 2019). He is a contributing author to the AUA's Core Curriculum and was co-author of “The Complete Business Guide for a Successful Medical Practice”. Dr. Stringer has served as Director for the AUA Annual Meeting course on Physician Contract Negotiation for Employment and Ownership since 2012. In June of 2016, Dr. Stringer was honored with the 2016 UF Department of Urology Resident Teaching Award. He was awarded the AUA's prestigious Presidential Citation in 2010. He writes and lectures nationally on the business of urology. He has been a member of the AUA since 1984.
David Amerson, MBA
David R. Amerson is the former President (retired 2021), of NeoTract Interventional Urology at Teleflex. He served as President and Chief Executive Officer and member of the Board of Directors for NeoTract, Inc. from 2011-2017 when the company was successfully acquired by Teleflex. Under his leadership, NeoTract to became a best-in- class medical device company. From 2006 to 2011, Mr. Amerson was Global Vice President, General Manager for the Urology division of Coloplast, a publicly traded medical equipment company based in Denmark. Mr. Amerson is a former board member of the Urology Society of America and the American Lithotripsy Society. He holds a MBA from Argosy University and a BA in Political Science from the University of West Georgia.
Arthur L. “Bud” Burnett, II, MD, MBA, FACS
Professor of Urology and Director of the Basic Science Laboratory in Neuro-urology at Johns Hopkins University School of Medicine
Dr. Burnett is recognized as a world-authority in the science and medicine of male erectile dysfunction and has contributed several original discoveries which have paved the way for the clinical development of oral medications to treat erectile dysfunction. His areas of expertise include prostate cancer, lower genitourinary tract malignancies and reconstruction, erectile dysfunction, penile abnormalities and female urology.
His extensive history with the Urology Care Foundation dates back more than 25 years when he first received a New Investigator Research Award in 1994. Since then, he has gone on to mentor six Foundation research awardees, for which he received the Foundation’s Distinguished Mentor Award in 2016. He most recently served on the Foundation’s Public Education Council and as Chair of the Foundation’s Reproductive and Sexual Health Committee.
Ryan D. Drant
Founder and Managing Director of Questa Capital Management
Mr. Drant specializes in healthcare investments in the medical device, healthcare services, healthcare information technology and specialty pharma sectors, and has been actively investing in healthcare since 1996. During his investment career, he has served on 33 boards of directors and has overseen the deployment of $950 million in equity capital. Mr. Drant was named four times to the Forbes Midas List of best venture capital investors.
Prior to founding Questa, Mr. Drant was a General Partner at New Enterprise Associates (NEA), where he joined in 1996, became a General Partner in 2004 and served on the firm's investment committee for 11 years spanning four funds totaling $8.0 billion in total capital. He led the firm's global healthcare investing practice and served as a member of NEA's four-person management committee. Previously, Mr. Drant was with the Health Care Investment Banking Group of Alex. Brown & Sons and Arthur Andersen & Co. Mr. Drant graduated from Stanford University with a BA in Political Science.
Larry Lipshultz, MD
Professor of Urology and Chief of the Scott Department of Urology's Division of Male Reproductive Medicine and Surgery
Dr. Lipshultz, who holds the Smith Chair in Reproductive Medicine, is a well-known authority on abnormalities of male reproduction, erectile dysfunction, and male hormone production. He also is the AUA's first Research Scholar.
Recognized as a leading expert on men's health, Dr. Lipshultz is a highly respected author and editor, as well as lecturer. His research has been in many journals, books and videos. Dr. Lipshultz instituted a fellowship training program in male reproductive medicine and surgery that has trained more than 80 physicians who are now in practice both in the U.S. and abroad.
Brian Keith McNeil, MD, MBA, FACS
Chief of Urology at SUNY Downstate Medical Center
One of New York's few African American uro-oncologists, Dr. Brian McNeil has been caring for patients in underserved communities in Central Brooklyn, NYC, for the past decade. His performance in treating urological cancer every day in addition to his voluntary front-line redeployment during the height of the COVID-19 pandemic was exemplary. Dr. McNeil is first and foremost an educator who, from 2017 to 2021, led and made outstanding contributions to the Urology Residency Program at SUNY Downstate, heavily represented by persons of color. He graciously accepted the position of Chief of the Urology Service at the University Hospital at Downstate to give back to a community similar to the one he grew up in. He has mentored numerous impressionable medical students and residents while serving as Associate Dean for Clinical Affairs at Downstate and is primarily responsible for advances in the senior year medical school curriculum. He has made sacrifices to both treat a predominantly indigent Afro-Caribbean population and train persons of color among the roster of urological specialists in the U.S.
Amarpreet Sawhney, PhD
Chairman of Instylla, Inc.
Dr. Sawhney is the CEO and Chairman of Instylla, Inc., a company focused on liquid embolic products for interventional oncology, and of Rejoni, Inc. a company developing products to decrease adhesion formation following intrauterine interventions. His entrepreneurism has facilitated the creation of several bio-pharma and medical device companies, as well as the development of such innovative technology solutions as ocular drug delivery systems to replace eyedrops, extravascular closure devices, surgical sealants and spacers that enable improved radiotherapy. Dr. Sawhney’s innovations are the subject of more than 120 issued and pending patents in medical devices, methods, and biomaterials. Many of his innovations have been “first of a kind” to be approved by the U.S. Food and Drug Administration.
He has been involved in several charitable causes including ones focused on education, the environment and creating platforms to support other healthcare entrepreneurs. Through his companies and inventions, Dr. Sawhney has touched more than five million patients and created more than 3,000 jobs.
Joseph A. Smith, MD
William L. Bray Professor in the Department of Urology at Vanderbilt University
Dr. Smith served as Chairman of the department from 1991 to 2015. Dr. Smith has served as President of the American Board of Urology, President of the Society of Urologic Oncology, President of the Southeastern Section of the American Urologic Association, and Chairman of the Residency Review Committee for Urology. He is a recipient of the Distinguished Contribution Award and the Hugh Hampton Young Award from the AUA. Dr. Smith is Editor of the Journal of Urology, the most widely read and highly cited journal in the specialty. He has been listed on Castle Connelly prestigious “Best Doctors” list for 25 consecutive years and was designated by Time Magazine as one of the top five surgeons in the country for treatment of cancer. His professional focus has been on innovative treatment strategies for patients with urologic cancers and introduction and evaluation of technologic advances in urologic surgery. He has performed over 1,000 radical cystectomies and 8,000 radical prostatectomies.
Mary Ann Lynn Stothers, MD, MHSc
Professor at the University of British Columbia in the Department of Urologic Sciences
Dr. Stothers serves as Associate Member of the School of Population and Public Health; Associate Member of the Department of Anesthesiology, Pharmacology and Therapeutics; and Associate Member of the Department of Obstetrics and Gynecology.
Dr. Stothers is a principal investigator at the International Collaboration on Repair Discoveries (ICORD), where she has a keen interest in the results and challenges following spinal cord injury. She is committed to her work with hospital foundations and other nonprofits and has been involved in raising funds for urology research and care for more 20 years. She enjoys her time volunteering with the Rick Hansen Institute and helping to raise funds for spinal cord injury research and education.
Suzette Sutherland, MD, MS, FPMRS
University of Washington Medical Center
Suzette E. Sutherland, MD, MS, FPMRS serves as Director of Female Urology and a member of the multi-disciplinary UW Medicine Pelvic Health Center at the University of Washington Medical Center, and Associate Professor in Urology at the University of Washington School of Medicine in Seattle, WA. Dr. Sutherland has served as a member of Foundation’s Bladder Health Committee and as Chair of the Technology & Publications Committee. Her contributions included the development, support, and dissemination of numerous patient educational materials through written brochures, UrologyHealth magazines, electronic means (QR codes) and podcasts.
Dr. Sutherland has collaborated with International Volunteers in Urology and local organizations to build capacity and research in urology and reproductive health throughout Africa.